PART 2: Dr. Robert Malone on Ivermectin, Escape Mutants, and the Faulty Logic of Vaccine Mandates

In part one of this American Thought Leaders episode, mRNA vaccine inventor Dr. Robert Malone explained the latest research on COVID-19 vaccines, booster shots, and natural immunity.

Now in part two, we take a closer look at repurposed drugs like ivermectin and how a universal vaccination policy could actually backfire—and bring about the emergence of vaccine-resistant escape mutants.

At their core, vaccine mandates are not just unethical and divisive, but also “impractical and unnecessary,” says Dr. Malone.

You can watch the first part of this episode here.

Below is a list of references mentioned or related to the discussion in this episode:
“Ivermectin for preventing and treating COVID-19” — The Cochrane Database of Systematic Reviews

“Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019” — Chest Journal

“Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19” — American Journal of Therapeutics

“Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” — Clinical Therapeutics

“Dexamethasone in Hospitalized Patients with Covid-19” — The New England Journal of Medicine

“ACTIV-6: COVID-19 Study of Repurposed Medications” — NIH

“Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals” — Cell Reports

“Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization” — Nature

The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines (Note: This is a preprint)

“Mutation rate of COVID-19 virus is at least 50 percent higher than previously thought” — Phys.org

“Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants” — The New England Journal of Medicine

“Why is the ongoing mass vaccination experiment driving a rapid evolutionary response of SARS-CoV-2?” — Trial Site News

“The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape” (Note: This is a preprint)

“The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines” (Note: This is a preprint)

“Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens” — PLOS Biology

“Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant” (Note: This is a preprint).

“Fauci: Amount of virus in breakthrough delta cases ‘almost identical’ to unvaccinated” — The Hill

CDC: “Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021”

“Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California” (Note: This is a preprint)

“New delta variant studies show the pandemic is far from over” — ScienceNews

“Read: Internal CDC document on breakthrough infections” — The Washington Post

“New UCSF study: Vaccine-resistant viruses are driving ‘breakthrough’ COVID infections” — The Mercury News

“Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections” (Note: This is a preprint)

“Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital” — Science

“Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint)

“SARS-CoV-2 variants of concern and variants under investigation in England” — Public Health England

“Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting” — The New England Journal of Medicine

“Real-World Study Captures Risk of Myocarditis With Pfizer Vax” — MedPage Today

CDC: “Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020—August 2021”

“CDC: Covid-19 Vaccine Effectiveness Fell From 91% To 66% With Delta Variant“ — Forbes

“SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans” — Nature

“Causes and consequences of purifying selection on SARS-CoV-2” — Genome Biology and Evolution

“The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus” — Journal of Travel Medicine

“Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint)

Subscribe to the American Thought Leaders newsletter so you never miss an episode.

You can also follow American Thought Leaders on Parler, Facebook, or YouTube. If you’d like to donate to support our work, you can do so here.

Follow Epoch TV on Facebook and Twitter.